MANGOCEUTICALS, INC.

MGRX

MANGOCEUTICALS, INC.

MGRX

Insider Sentiment (TTM):

Last Purchase:2023-04-10Last Sale:2025-12-15Shares Purchased (TTM):0Shares Sold (TTM):143,333

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:765,510Shares Outstanding:16,481,607Institutional Ownership Pct.:4.64%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	0	0	1	0	0	0	0	0	0	0	1	1
Inventory Net	-	-	-	-	-	-	-	0	0	0	0	0
Assets Current
Assets Current	0	0	2	1	0	0	0	0	1	0	1	1
Prepaid Expense Current	-	-	-	0	-	-	-	-	-	-	-	-
Deposits Assets Current	0	0	0	0	0	-	0	-	-	-	0	-
Other Receivables Net Current	-	0	0	-	-	-	-	-	-	-	-	-
Property Plant And Equipm…
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets Noncurrent
Assets Noncurrent	14	14	15	16	21	22	15	15	-	-	0	-
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	14	14	14	16	21	22	15	15	15	-	-	-
Assets	14	14	16	17	21	22	15	15	15	0	1	2
Liabilities And Stockhold…
Other Assets
Other Assets	-	-	-	-	-	-	-	-	0	0	0	0
Deposits Assets	-	-	-	-	-	-	-	-	0	0	0	0
Accounts Payable And Accrued Liabilities Current	1	1	0	1	1	1	1	-	1	-	0	0
Liabilities Current
Liabilities Current	1	1	1	1	2	2	1	1	1	1	0	0
Notes Payable Current	-	-	-	-	-	-	0	-	-	-	-	-
Accrued Payroll Taxes Current	0	0	0	0	0	-	-	0	0	0	0	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities Current	-	-	-	-	-	-	0	0	0	-	-	-
Liabilities Noncurrent
Liabilities Noncurrent	0	0	-	-	-	-	-	0	0	0	0	0
Operating Lease Liability Noncurrent	0	0	-	-	-	-	-	0	0	0	0	0
Liabilities	2	1	1	1	2	2	1	1	1	1	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Share Subscribed But Unissued Subscri…	-	-	-	-	-0	-	-1	-0	-1	-	-	-
Stockholders Equity
Additional Paid In Capital	58	57	56	53	51	46	35	32	30	13	12	10
Stockholders Equity	13	13	15	16	19	20	14	14	14	-1	1	1
Retained Earnings Accumulated Deficit	-45	-44	-41	-38	-32	-26	-20	-18	-16	-14	-11	-9
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-	-
Minority Interest	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-	-
Liabilities And Stockholders Equity	14	14	16	17	21	22	15	15	15	0	1	2
Accumulated Depreciation Depletion And Amortizatio…	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	-	-	-
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	-	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	18	17	16	14	11	7	3	32	2	2	1	1
Shares Outstanding	18	17	16	14	0	7	3	32	2	2	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-13.56%	-11.62%	19.13%	-	-	-	-	-	-	-	-	-
2025	47.83%	7.97%	23.91%	39.87%	43.67%	31.65%	-25.68%	-42.36%	-75.61%	15.83%	25.28%	-11.94%
2024	96.35%	42.47%	66.67%	-18.24%	-33.43%	-54.20%	6.28%	3.97%	26.57%	-64.02%	-59.66%	-53.10%
2023	-	-	-	-	-	-	-40.68%	-63.80%	-64.03%	22.33%	91.16%	58.14%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.18	0.29	1.74	0.74	0.07	0.12	0.05	0.07	0.38	0.07	3.96	8.44
Quick Ratio	0.18	0.29	1.74	0.62	0.07	0.12	0.05	0.07	0.37	0.06	3.87	8.30
Working Capital	-1.15M	-525.13K	656.87K	-206.05K	-1.48M	-1.33M	-1.35M	-1.29M	-860.70K	-1.12M	624.32K	1.18M
Leverage & Debt
Debt to Equity	0.13	0.07	0.06	0.05	0.08	0.07	0.10	0.10	0.10	-1.31	0.36	0.18
Interest Coverage TTM	-129.27	-141.47	-137.74	-171.37	-375.16	-743.12	-	-	-	-1,096.49	-922.53	-
Debt Ratio	0.12	0.07	0.06	0.05	0.08	0.07	0.09	0.09	0.09	4.18	0.26	0.15
Efficiency & Turnover
Asset Turnover TTM	0.02	0.02	0.03	0.03	0.03	0.05	0.08	0.09	0.09	0.38	0.70	-
Per Share Metrics
Diluted EPS TTM	-0.85	-1.15	-2.05	-1.75	-1.48	-2.50	-4.40	-4.78	-5.24	-5.92	-8.58	-
Free Cash Flow Per Share TTM	-0.28	-0.30	-0.58	-0.31	-0.36	-1.34	-2.46	-2.70	-3.44	-4.06	-6.52	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Margin Metrics
Gross Profit Margin TTM	54.43%	52.42%	54.91%	60.61%	61.00%	57.65%	61.70%	58.60%	58.19%	61.75%	58.99%	-
Operating Profit Margin TTM	-3,916.81%	-3,999.79%	-3,954.28%	-4,083.34%	-2,573.61%	-1,991.99%	-1,294.42%	-1,173.83%	-1,027.21%	-1,068.50%	-1,260.28%	-
Net Profit Margin TTM	-4,604.80%	-4,561.92%	-4,526.76%	-4,308.65%	-2,866.48%	-2,244.84%	-1,413.80%	-1,274.15%	-1,052.86%	-1,067.52%	-1,259.40%	-
Growth Metrics
Net Revenue Growth (1Y)	-38.91%	-18.88%	-25.96%	-38.16%	-40.47%	-39.51%	-15.81%	-	-	-	-	-
Net Income Growth (1Y)	-1.87%	64.85%	137.08%	109.12%	62.08%	27.21%	-5.48%	-	-	-	-	-
EPS Growth (1Y)	-42.77%	-54.06%	-53.42%	-63.46%	-71.75%	-57.82%	-48.70%	-	-	-	-	-
Valuation Metrics
P/E TTM	-0.45	-0.31	-0.36	-1.25	-1.03	-0.78	-0.55	-0.74	-0.87	-0.55	-0.48	-
P/B TTM	0.52	0.44	0.49	1.60	0.79	0.44	0.34	0.52	0.57	-5.17	5.76	10.00
P/S TTM	20.64	14.31	16.34	54.05	29.41	17.52	7.78	9.44	9.15	5.87	6.10	-
Market Cap	6.51M	5.93M	7.45M	25.24M	15.17M	8.96M	4.79M	7.13M	7.93M	4.96M	4.46M	13.55M
Enterprise Value	6.28M	5.76M	6.63M	24.76M	15.07M	8.88M	4.88M	7.06M	7.44M	4.94M	3.72M	12.31M
Calculated Values
Free Cash Flow TTM	-4.85M	-4.89M	-5.85M	-3.63M	-3.55M	-6.15M	-4.86M	-5.43M	-5.98M	-6.18M	-7.00M	-
Net Debt	-228.69K	-174.56K	-827.54K	-481.28K	-101.02K	-76.50K	91.35K	-73.91K	-490.24K	-15.31K	-739.01K	-1.24M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-15Sale

Owner: Johnston, Eugene M

Title: CFO

Shares: 3,333

Price/Share: $1.17

Value: $3,899.61

Shares Owned: 120,000

Relationship: Officer

Ownership: Direct

2025-12-09Sale

Owner: Johnston, Eugene M

Title: CFO

Shares: 5,000

Price/Share: $1.20

Value: $6,000.00

Shares Owned: 123,333

Relationship: Officer

Ownership: Direct

2025-12-05Sale

Owner: Johnston, Eugene M

Title: CFO

Shares: 10,000

Price/Share: $1.13

Value: $11,300.00

Shares Owned: 128,333

Relationship: Officer

Ownership: Direct

2025-11-19Sale

Owner: Hamilton, Alex P.

Title: -

Shares: 125,000

Price/Share: $1.22

Value: $152,500.00

Shares Owned: 3,334

Relationship: Director

Ownership: Direct

2024-06-26Sale

Owner: Hamilton, Alex P.

Title: -

Shares: 108,426

Price/Share: $0.32

Value: $34,696.32

Shares Owned: 50,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-15	Johnston, Eugene M	Officer	CFO	Direct	Sale	3,333	1.17	$3,899.61	120,000	4
2025-12-09	Johnston, Eugene M	Officer	CFO	Direct	Sale	5,000	1.20	$6,000.00	123,333	4
2025-12-05	Johnston, Eugene M	Officer	CFO	Direct	Sale	10,000	1.13	$11,300.00	128,333	4
2025-11-19	Hamilton, Alex P.	Director	-	Direct	Sale	125,000	1.22	$152,500.00	3,334	4
2024-06-26	Hamilton, Alex P.	Director	-	Direct	Sale	108,426	0.32	$34,696.32	50,000	4
2023-04-10	Tiger, Cub Trust, Cohen J…	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	275,000	1.00	$275,000.00	8,275,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

4.64%

Inst. Shares: 765,510

Shares Outstanding: 16,481,607

2025-12-31

24.86%

Inst. Shares: 2,503,563

Shares Outstanding: 10,071,609

2025-09-30

3.25%

Inst. Shares: 374,558

Shares Outstanding: 11,524,275

2025-06-30

3.97%

Inst. Shares: 289,367

Shares Outstanding: 7,282,955

2025-03-31

1.64%

Inst. Shares: 75,317

Shares Outstanding: 4,593,062

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	765,510	16,481,607	4.64%
2025-12-31	2,503,563	10,071,609	24.86%
2025-09-30	374,558	11,524,275	3.25%
2025-06-30	289,367	7,282,955	3.97%
2025-03-31	75,317	4,593,062	1.64%
2024-12-31	57,399	1,978,966	2.90%
2024-09-30	1,307,176	2,013,848	64.91%
2024-06-30	384,945	1,739,969	22.12%
2024-03-31	228,561	1,574,634	14.52%
2023-12-31	75,040	1,074,202	6.99%
2023-09-30	103,880	1,061,572	9.79%
2023-06-30	90,952	1,052,016	8.65%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MANGOCEUTICALS, INC. (MGRX) — SEC Financial Statements & Analysis

MANGOCEUTICALS, INC. (MGRX) is a services-misc health & allied services, nec company, incorporated in TX. MANGOCEUTICALS, INC. trades on Nasdaq as: MGRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MANGOCEUTICALS, INC. reported a -38.91% year-over-year revenue growth, a Gross Profit Margin of 54.43% (TTM), a Debt-to-Equity ratio of 0.13x, a Price-to-Sales (P/S) ratio of 20.64x (TTM), a Price-to-Book (P/B) ratio of 0.52x (TTM), at a market cap of $6.51M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -38.91%
Gross Profit Margin TTM: 54.43%
Debt To Equity: 0.13x
P/S TTM: 20.64x
P/B TTM: 0.52x
Market Cap: $6.51M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MANGOCEUTICALS, INC. in?

MANGOCEUTICALS, INC. (MGRX) operates in the Services-Misc Health & Allied Services, NEC industry.

What is MGRX's market cap?

MANGOCEUTICALS, INC. (MGRX) has a market capitalization of $6.51M as of 2026-06-30.

What exchange does MGRX trade on?

MANGOCEUTICALS, INC. (MGRX) trades on the Nasdaq.

Where is MANGOCEUTICALS, INC. incorporated?

MANGOCEUTICALS, INC. is incorporated in TX.